Skip to main content
The Markets by Proactive
Go to Proactive Australia

Pharma & Biotech

Sareum Holdings represents UK at cancer cluster conference

Sareum is one of three companies from the UK "Golden Triangle" biotechnology cluster.

Sareum Holdings Plc (LON:SAR) is to highlight its research pipeline at the 6th annual International Cancer Cluster Showcase at the San Diego Convention Center.

Tim Mitchell, chief executive, will be showcasing Sareum as one of three companies from the UK "Golden Triangle" biotechnology cluster (London, Oxford and Cambridge).

The event is organised as a satellite to the BIO International Convention, the world's largest gathering for the global biotech industry.

Over 200 representatives from the international oncology community are expected to participate in the network meeting.

Tim Mitchell said: "We are delighted that Sareum has been selected to represent British cancer research at this prestigious event."

Watch: Cancer drug payment nudges Sareum Holdings into maiden profit